It has long been assumed that the primary influences regulating cardiac contractility are the extent of mechanical loading of muscle fibers and the activity of the autonomic nervous system. However, the vasoactive peptide endothelin, initially found in vascular endothelium, is among the most potent positively inotropic agents yet described in mammalian myocardium. In isolated adult rat ventricular cells, endothelin's action was slow in onset but very long lasting with an EC5. of 50 pM that approximates the reported KD of the peptide for its receptor in rat heart. When the calcium activity of the buffer superfusing isolated single fura-2-loaded myocytes paced at 1.5 Hz was varied from 0.1 to 0.9 mM [Ca2"L, 100 pM endothelin increased contractile amplitude with no significant change in diastolic or systolic [Ca2+J, thus appearing to sensitize the myofilaments to intracellular calcium. Pertussis toxin, or prior exposure to a f8-adrenergic agonist, reduced or abolished the increase in myocyte contractility induced by endothelin. This novel and potent pharmacologic action of endothelin points to the potential importance of local, paracrine factors, perhaps derived from microvascular endothelium or endocardium, in the control of the contractile function of the heart. (J. Clin.
Introduction
Endothelial cells have been identified as the source of a number of biologically active factors that act in a paracrine fashion to influence the behavior of both blood-borne elements and subjacent vascular tissue (1) (2) (3) . One such factor is the potent vasoconstrictor endothelin, originally identified by Masaki and colleagues in conditioned media from primary cultures of porcine aortic endothelial cells (4) . Their initial reports describing endothelin's positive inotropic effect (i.e., increasing contractility) in guinea pig atria, and its action on the secretion of atrial natriuretic peptide in primary cultures of neonatal rat atrial myocytes (5-7) have been confirmed by several laborato-ries (8) (9) (10) (11) (12) (13) (14) (15) . Subsequently, high-affinity receptors for endothelin have been identified by several groups in mammalian atria and ventricles (16) (17) (18) (19) (20) (21) . We report here that endothelin is the most potent positively inotropic agent we have tested in isolated adult rat ventricular myocytes. This inotropic effect was abolished by pretreatment with pertussis toxin, thus implicating a guanine nucleotide regulatory (G) protein or proteins in the sequence of steps leading to the inotropic response.
Masaki and colleagues have now demonstrated that at least three isoforms of endothelin are coded in the mammalian genome, all very similar structurally, but varying in the hydrophilicity of their NH2-terminal sequences (22) . These peptides have qualitatively similar pharmacodynamic effects, although the pharmacokinetics of their action on varying tissues could differ. For the purpose ofthis report, "endothelin" refers to the originally described porcine/human endothelin, now termed "endothelin-1." Methods Calcium-tolerant isolated rat ventricular myocytes were prepared using a variation of the methods described by Haworth et al. (23) and Cheung et al. (24) . Briefly, hearts were perfused with a Krebs-Henseleit bicarbonate buffer containing nominally 0 Ca2 , collagenase, and hyaluronidase (Worthington Biomedical, Malvern, PA). Ventricles were minced and incubated in the same buffer containing trypsin and 1 mM CaC12, and cells were released by trituration and sedimentation in 2% BSA. The yield of rod-shaped cells (1.5-2.0 X 106 cells/heart) in the top layer of the cell suspension with clear cross-striations that excluded trypan blue was routinely > 95%. The myocytes were then allowed to attach to 12-mm glass coverslips that had been coated with collagen (Vitrogen 100; Collagen Corp., Palo Alto, CA) for contractility measurements. For measurement of intracellular Ca2 , cells were first loaded with fura-2/AM by incubating 2 ml of cell suspension (-5 X 10" cells/ml) with 0.1 ml of a 4.8 ,uM fura-2/AM stock solution (0.5 ml of 1 mM fura-2/AM in dry DMSO with 0.1 ml 25% (wt/wt) Pluronic F127 in DMSO (Molecular Probes Inc., Eugene, OR) and 4.4 ml FCS). The cells were then washed in Hepes-buffered medium (below), and allowed to attach to glass coverslips coated with liquid collagen (Vitrogen, Collagen Corp.) and stored in the dark until use. The fura-2 stock solution was sonicated and stored at -70°C in aliquots for future use. Endothelin (synthetic porcine/human endothelin-1) was purchased from Penisula Laboratories Inc. (Belmont, CA). The lyophilized peptide was reconstituted in 1.0 mM acetic acid to a final concentration of 40 uM, aliquoted, and kept at 4°C for no longer than 2 wk. To minimize nonspecific adsorption of the peptide to surfaces, all dilute solutions ofendothelin were maintained in 0.05% BSA (Fraction V; Sigma Chemical Co., St. Louis, MO).
velocity of cell shortening varied linearly with contractile amplitude, and, therefore for convenience, only the latter data are presented here. Cell shortening and relaxation were monitored using a video motion detector that provided new position data every 16 ms. In cells not exposed to agonist, the absolute magnitude of shortening varied from 1-5 gm (mean 3.79±1.40 Mm; ±SD), increasing to > 10-fold in the presence of high concentrations of external calcium or isoproterenol.
For the simultaneous measurement of contractility and [Ca2+]i, isolated adult rat ventricular myocytes were loaded with the calcium-selective fluorescent dye fura-2 (1-[245-carboxyoxazol-2-yl)-6-aminobenzofuran-5-oxyl]-242'-amino-5'-methylphenoxy)ethane-N,N,N',N'-tetraacetic acid) (Molecular Probes Inc.). Coverslips containing attached fura-2-loaded myocytes were transferred to a circular superfusion chamber 1 2-mm-diam, 300 1A in volume, mounted on the stage of an inverted epifluorescence microscope (Nikon, Diaphot). The coverslips were superfused by a peristaltic pump at a flow rate of I ml/min. Both the chamber and superfusate were kept at 370C by a circulating water bath. The microscope was connected to a dual excitation fluorometer (Spex Industries, Inc., Edison, NJ). The excitation wavelengths were 340/380±1.8 nm. The emission spectrum of fura-2 at each excitation wavelength was monitored at 500±5 nm, with a time resolution for acquisition of ratioed data of 3 ms. To minimize photobleaching of the dye, a 50% neutral density filter was inserted in the excitation beam path. The cells were also illuminated with light at a wavelength above 600 nm in the phase contrast mode. An additional postspecimen dichroic mirror deflected light at wavelengths below 450 nm to a video camera, thereby minimally affecting the emission light from fura-2. Ventricular myocytes were loaded with 2 MM fura-2/AM (the acetoxymethylester of fura-2) for 30 min at room temperature in superfusion buffer. This step reduced the amplitude of contraction of individual cells by no more than 10% at 0.9 mM Ca2+.
Because the positive inotropic response to endothelin was slow in onset, preliminary experiments were performed to characterize the contractile response offura-2-loaded myocytes monitored on the stage ofan epifluorescence microscope at 370C for up to 90 min. In contrast to our experience monitoring the behavior of isolated ventricular myocytes in a standard phase-contrast microscope, myocyte contractility was markedly reduced in fura-2-loaded cells constantly exposed to UV light at 340 and 380 nm. Whether this deleterious effect was directly related to cellular toxicity due to UV light, or to a toxic metabolite of fura-2 as a consequence of photobleaching, is unclear. Therefore, in protocols involving fura-2-loaded myocytes, the contractile response ofindividual cells illuminated by a standard microscope light source was monitored until a plateau was reached following a change in the superfusion medium. A "snapshot" of the calcium transients lasting < 30 s was then obtained by opening an electronic shutter, thus minimizing the total cellular exposure to UV light to < 7 min during an entire protocol. This toxic effect was accelerated by exposure to high (5.4 Fura-2 displays a hypsochromic effect of 6 nm on binding La 3 with both hyperchromic (at 340 nm) and hypochromic (at 380 nm) effects, and an affinity for La3+ that is much higher than for Ca2+ or for Mn2+; therefore, correction factors have been derived and validated (25) .
Although the sampling rate of the spectrofluorometric instrumentation used in collecting the data in this report was sufficiently rapid (a ratioed fura-2 signal every 3 ms) to capture systolic and diastolic values for cytosolic Ca2' reliably, no comment can be made about the rate of decline of intracellular Ca2+ transients in control, isoproterenol or endothelin-treated cells due to the concern that the dissociation rate of Ca2+ from the fura-2/Ca2+ complex might limit the resolution of the time course of the decline in cytosolic [Ca2i] .
Exposure of myocytes to pertussis toxin. Freshly isolated rodshaped cells were suspended in Hepes-buffered medium and incubated at 37°C with 100 ng/ml pertussis toxin for 3 h. The in vitro ADP-ribosylation reaction then was performed at 37°C for 40 min as previously described (27) . Analysis of protein bands was performed on 11% acrylamide gels prepared according to Laemmli (28) . Dried gels were exposed to Kodak XAR film with enhancing screens for 1-2 d at -700C. Autoradiographs were scanned on a laser densitometer (LKB Instruments, Inc., Gaithersburg, MD). 
Results and Discussion
Endothelin and myocyte contractile amplitude. To obviate the potential complication of diffusion limitations and the presence of cells other than myocytes that might bind and metabolize the peptide in intact tissue preparations, we studied the calcium-tolerant isolated adult rat ventricular myocyte, an experimental model that has been characterized in detail in our laboratory. In Fig. 1 , the contractile response of isolated ventricular myocytes is plotted as a function of endothelin concentration in the bathing media. Due to a tendency for cells to have a diminished response to higher doses ofthe peptide after a 7-10-min exposure at a lower concentration (e.g., 0.5-10 pM), the concentration-effect curve was constructed testing individual cells at one endothelin concentration only (n = 6-10 cells at each point).
In this preparation, it was apparent that endothelin was the most potent positively inotropic agent we have tested to date, with a characteristic slow onset and long duration of action. Although occasional cells showed a definite response between 10 and 100 fM, consistent responses were apparent only above 0.5 pM; the EC50 was 50 pM. In (Fig. 2 B, open diamonds) . Step in [Co ] protocol (mM) switched to endothelin-containing medium. Importantly, despite a marked increase in contractile amplitude that averaged 234% (n = 3) of baseline at 0.9 mM Ca2" (Fig. 2 A) , there was no significant increase in the systolic Ca2+ (Fig. 2 B) ined, as shown in Fig. 3 A, endothelin appears to increase myofilament responsiveness to cytosolic calcium. To determine ifthis pharmacologic response to endothelin was qualitatively different from that observed with another positively inotropic agent, rat ventricular myocytes were exposed to either 100 pM endothelin or low concentrations of the f3-adrenergic agonist isoproterenol that resulted in similar increases in contractile amplitude. As illustrated in Fig. 3 These observations are made on unloaded cells; that is, the cells undergo shortening against an internal load that is presumed to be constant (isotonic), as opposed to contraction against an external load which more closely represents conditions in vivo. Nevertheless, some recent observations support the usefulness of the isolated myocyte model in the study of cardiac contractility. Lee and Allen, in isolated ferret papillary muscles, have shown qualitatively similar results of several interventions on contractile performance measured either as isotonic muscle shortening or isometric tension development (31) . In addition, Kent et al. have recently shown that the rate and extent of shortening of unfettered isolated feline myocytes is analogous to the force-velocity relationship ofisolated linear cardiac muscle (33) .
The evidence presented here that endothelin enhances myocyte contractility in the absence of substantial changes in time averaged [Ca2+] i or in the cystolic [Ca2+]i transient is of interest in relation to recent observations on the mechanism of action of a-adrenergic agonists (33, 34) . In intact aequorinloaded rabbit papillary muscles (34) Fig. 5 , verapamil had the expected negative inotropic effect in control cells, with an IC50 of -0.5 MM. Verapamil also decreased the absolute magnitude of inotropic response to endothelin. However, it is of interest that the relative fall in contractile amplitude in cells treated with 100 pM endothelin (-33% at 1 MM verapamil) was less than that seen in control cells (-a 60% decline at 1 uM). This suggests that the response to endothelin is relatively unaffected by or resistant to reduced Ca2+ conductance through sarcolemmal L-type channels, and is consistent with the hypothesis that endothelin may be increasing contractile amplitude by a novel mechanism, perhaps by increasing contractile element sensitivity to intracellular calcium. It is also possible that endothelin indirectly affected verapamil's binding to or action at sarcolemmal L-channels by use-dependent blockade, perhaps due to membrane hyperpolarization, although this seems less likely.
Pertussis toxin and the inotropic response to endothelin. As GTP binding proteins have been shown to be important intermediates in the transduction of many signals at the cell membrane, including those that initiate phosphatidylinositol hydrolysis and Ca2" mobilization, we tested whether pertussis toxin-sensitive G proteins might be involved in the sequence ofevents after endothelin-receptor binding (37) . The relatively prolonged time to onset of the positive inotropic effect of endothelin was also of interest in view of recent evidence from several laboratories that endothelin rapidly induces phosphatidylinositol hydrolysis or activation of phospholipase A2 in a number of tissues, including rat atrium (13, 39-41a) . Therefore, we also determined whether early pharmacologic effects ofthe peptide, possibly mediated by pertussis toxin-sensitive G proteins, could be unmasked during the 4-to 5-min lag phase preceding the positive inotropic effect of the peptide.
Preincubation of freshly dissociated intact rat ventricular myocytes with pertussis toxin resulted in nearly complete abolition of subsequent pertussis toxin-induced [32P]ADPribosylation in membranes derived from these pretreated cells 1168 Kelly, Eid, Kramer, O'Neill, Liang, Reers, and Smith non-G protein-related rapid effects of pertussis toxin in the response of rat cardiac myocytes to endothelin.
As an additional control, isolated ventricular myocytes were incubated in the presence or absence of 100 ng/ml pertussis toxin for 3 h at 37°C in Hepes-buffered medium, and then exposed to 10 nM isoproterenol. Pertussis toxin pretreatment increased the rise in contractile amplitude with isoproterenol to 400% of control (n = 2) compared to 150% of control (n = 2) in nonpertussis toxin-pretreated cells, as expected in response to a ,B agonist after pertussis toxin. Also, although the time course of the rise in contractile amplitude was delayed, pertussis toxin had no effect on the maximal increase in contractile amplitude to either 10 gM phenylephrine or 100 nM angiotensin in similarly treated isolated myocytes.
The unmasking of an early negative inotropic effect of endothelin in many cells by pertussis toxin, with the subsequent abolition or marked diminution of the positive inotropic action of the peptide, suggests a complex signal transduction mechanism. The negative inotropic effect could be mediated by protein kinase C, since we have observed a decrease in contractility in response to phorbol ester exposure in primary cultures of embryonic chick cardiocytes (44) . An additional, surprising observation was the effect of prior exposure of rat ventricular myocytes to isoproterenol on their subsequent contractile responsiveness to endothelin. Exposure of myocytes to low concentrations (10-100 nM) of isoproterenol for 30-40 s resulted in a mean 2.6-fold increase in contractile amplitude, followed by a return to baseline contractility after a 5-min washout. After this brief isoproterenol exposure, the circles; n = 9) or preincubation at 37°C in control media (solid circles; n = 5), and the change in contractile amplitude was recorded.
Endothelin Increases Cardiac Myocyte Contractile Response to Calcium contractile response to 100 pM endothelin was completely abolished in six of seven cells. In four of these seven cells, contractility initially declined upon exposure to endothelin, returning to baseline or slightly above only after 10 min of exposure to the peptide. This indicates that ,3 agonists can modify cellular responsiveness to endothelin's action, perhaps by partially uncoupling the activated receptor from a signal transducing G protein. jB agonists could also affect another step or steps downstream in the signal transduction cascade, as they are known to desensitize myofilament responsiveness to cytosolic Ca2", due at least in part to phosphorylation oftroponin I in response to increased cAMP levels. This explanation is the more intriguing possibility given our data supporting endothelin's action enhancing myofilament sensitivity to calcium.
These observations indicate that endothelin is among the most potent inotropic substances for mammalian myocardium yet described, with a mechanism of action qualitatively different from many other endogenous agents and drugs that increase cardiac contractility. The EC50 of endothelin in isolated ventricular myocytes is at or below 50 pM, in accord with binding affinities for the cardiac sarcolemmal endothelin receptor determined in either intact tissue or sarcolemmal membranes (16) (17) (18) (19) (20) (21) . The onset of endothelin's action is slow while its duration is prolonged, indicating that the peptide, if it acts as an endogenous regulator of myocardial contractility in vivo, may modulate the inotropic responsiveness of the myocardium over a timeframe of minutes to hours, possibly by sensitizing the myofilaments to changes in cytosolic calcium induced by the more rapid, but shorter-lived effects of neurohumoral factors. Although an increase in cytosolic calcium in single isolated ventricular cells has been documented at endothelin concentrations of 20 nM (45), we did not observe any consistent increase in systolic or diastolic calcium at concentrations below 1 nM.
An alternative explanation for our failure to witness an increase in intracellular Ca2", aside from the lower concentration of endothelin used here, is our choice of species. The increase in cytosolic Ca2" noted in rabbit myocytes (45) was accompanied by an increase in action potential duration to 470 ms. The rat action potential is, by contrast, much abbreviated. Although we did not measure action potential duration, other qualitative differences in the force-frequency relationship between the rat and other mammalian species point to important differences in intracellular Ca2' homeostasis (46) that could explain the absence of a rise in cytosolic Ca2" with endothelin in the rat but not in the rabbit and, perhaps, other species. Regardless, at the stimulation frequency used here, 1.5 Hz, the absence ofany detectable rise in cytosolic Ca2+ implies that some sensitization of the contractile apparatus to Ca2+ occurred, an effect that might be apparent, to a greater or lesser degree, in other species. Our findings suggest that the microvascular and/or endocardial endothelium of the heart, if it is the relevant source of the peptide in myocardium, and is analogous to the role described for endothelium in conduit and resistance vessels, may play a role in the modulation of cardiac contractile state, perhaps in response to changes in microvascular blood flow. Also, recent reports that the endocardial endothelium appears to modulate the inotropic response to changes in [Ca2+]o in papillary muscle (47, 48) are consistent with our observations that an endothelium-derived factor increases the contractile responsiveness to calcium. Irrespective of the mechanism, endothelin may be one of a number of endogenous autacoids released by microvascular or endocardial endothelium, and transported vectorially to subjacent cardiac myocytes, that can act to regulate cardiac function.
